WinSanTor Competitors and Similar CompaniesClear all
WinSanTor's competitors and similar companies include Merck, Applied Therapeutics, Ainos and Abarceo Pharma.
 WinSanTor WinSanTor is a clinical-stage biotechnology company that engages in the discovery and development of treatments for peripheral neuropathies. |  Merck Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health. |  Applied Therapeutics Applied Therapeutics is a clinical-stage biopharmaceutical company developing therapies for diabetic complications. |  Ainos Ainos (formerly known as Amarillo Biosciences) is a healthcare company that specializes in the development of novel biopharmaceuticals, medical treatments, and specialty consumer products. | ||
Founding Date | Founding Date 2011 | Founding Date 1891 | Founding Date 2017 | Founding Date 1984 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Rahway, US HQ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE Santa Cruz De La Sierra, BO see more | Locations New York, US HQ | Locations Amarillo, US HQ Taipei, TW | Locations Malmö, SE HQ |
Employees | Employees 910% decrease | Employees 73,0004% increase | Employees 1110% increase | Employees 4326% increase | Employees 910% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 294.7 b | Valuation ($) 1 b | Valuation ($) 4.4 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $65b (FY, 2025) | Revenue (est.) $455k (FY, 2024) | Revenue (est.) $124.2k (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $16.4b (FY, 2025) | Cost of goods N/A | Cost of goods $21.2k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $48.6b (FY, 2025) | Gross profit N/A | Gross profit $102.9k (FY, 2025) | Gross profit N/A |
Net income | Net income ($1m) (FY, 2024) | Net income $18.3b (FY, 2025) | Net income ($105.6m) (FY, 2024) | Net income ($14.8m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Merck
HQ
Rahway, US
Employees
73,000↑ 4% increase
Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health.
View companyApplied Therapeutics
HQ
New York, US
Employees
11↑ 10% increase
Applied Therapeutics is a clinical-stage biopharmaceutical company developing therapies for diabetic complications.
View companyAinos
HQ
Amarillo, US
Employees
43↑ 26% increase
Ainos (formerly known as Amarillo Biosciences) is a healthcare company that specializes in the development of novel biopharmaceuticals, medical treatments, and specialty consumer products.
View company
Abarceo Pharma
HQ
Malmö, SE
Employees
9↓ 10% decrease
Abarceo Pharma is a company that develops therapeutics for type-2 diabetes.
View company